Actively Recruiting
Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer
Led by Affiliated Hospital of Qinghai University · Updated on 2025-01-14
162
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Electroacupuncture treatment of peripheral neuropathy after taxane chemotherapy for breast cancer
CONDITIONS
Official Title
Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Breast cancer patients diagnosed by pathology
- EOOG score is 0 or 1
- Age between 18 and 75 years old
- Accept chemotherapy regimens based on taxane drugs (alone or in combination)
- Previously received taxane chemotherapy for more than 6 months
- Report chemotherapy-induced peripheral neuropathy symptoms of grade 1 or higher for more than 2 weeks
- Voluntarily participate and sign informed consent
- Accept regular follow-up visits
- Have complete pathological data available
You will not qualify if you...
- Not diagnosed with breast cancer
- Received electroacupuncture treatment within 6 months prior to the study
- Experienced intolerable toxic side effects during standard dose chemotherapy causing termination
- History of peripheral neuropathy before enrollment
- Unstable heart disease or myocardial infarction within 6 months before the study
- Active skin diseases, ulcers, or infections that cannot tolerate electroacupuncture
- Uncontrolled epilepsy with seizures
- Presence of other malignant tumors
- Pregnancy or lactation
- Refusal to join the clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qinghai University Affiliated Hospital
Xining, Qinghai, China, 810001
Actively Recruiting
Research Team
G
Guoshuang Shen G Administrative Director of Breast Center, Affiliated Hospital
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here